Skip to main content

Duquesne Family Office LLC

Family Office

Position in INSM — INSMED Inc

CIK 1536411 New York, NY

Position in INSM

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$188,716,796
-$69,167,322 QoQ
Shares Held
1,154,090
-22.1% QoQ
Ownership
0.532%
of shares outstanding
% of Portfolio
6.82%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
9 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in INSM Over Time

Shares Held

Position Value (USD)

Derivatives in INSM

reported options exposure · as of Jun 30, 2025
CallValue
$10,064,000
CallShares
100,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Duquesne Family Office LLC holds $456,583,855 across 12 Biotechnology names. INSM ranks #1 (41.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INSM
INSMED Inc
This page
1,154,090 $188,716,796

All Filings in INSM

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $188,716,796 1,154,090
2025-12-31 $257,884,118 1,481,752
2025-09-30 $348,998,874 2,423,435
2025-06-30 $226,785,698 2,253,435
2025-06-30 $10,064,000 100,000
2025-03-31 $104,444,824 1,369,050
2024-12-31 $40,973,168 593,470
2024-09-30 $1,460,000 20,000
2024-06-30 $1,340,000 20,000
2020-06-30 $33,802,596 1,227,400